Leader in Antifungal R&DLeader in Antifungal R&DLeader in Antifungal R&DLeader in Antifungal R&D
Overview
R&D
Management & Board
Advisors
Advisor Meetings
Scientific Services
Publications
Careers
Press Releases
Useful Links
Contact Us
Management Board - Christopher Wright
.
 

Christopher Wright - M.A., Non Executive Director

Is a director of Merifin Capital Group, a private European investment firm and an advisory director of Campbell Lutyens & Co Ltd, a London based investment bank. Prior to this he served as Head of Global Private Equity for Dresdner Kleinwort Capital (c.$4.5bn under management). He has acted as Chairman of various investment funds prior to and following the latter's integration with Allianz Private Equity. Mr. Wright has spent over 19 years financing and advising smaller and mid-sized companies operating in the USA, Canada, Asia and Europe. He joined Kleinwort Benson Limited in London in 1978 and in 1981 co-founded the Group's offices in Los Angeles. In 1986 he relocated to New York to manage the Kleinwort Benson Limited portfolio of North American private equity and mezzanine investments.

He is Chairman of Noble Venture Finance Ltd, 75 Wall Street Technology Partners LLC.; and holds directorships of : Lombard Risk Management PLC ( LSE ); Roper Industries Inc ( NYSE ); Genaissance Pharmaceuticals Inc ( NASDAQ ); F2G Ltd, Maxcess International Corporation; Mrs. Fields Holdings LLC; I-documentsystems Group PLC ( LSE ) and Tritex Corporation. He has also chaired and/or serves on several advisory boards of third party managed LBO and venture capital funds in North America and Europe.

Mr Wright was educated at Oxford University ( M.A.) and holds a C.Diploma in Accounting and Finance.

Back


F2G Ltd, PO Box 1, Lankro Way, Eccles, Manchester, M30 0BH
Tel +44 (0)161 785 1270 Fax +44 (0)161 785 1273 Email contact@f2g.com